adagene.com (ADAG) - Cash Funds Volume per Share

Adagene minimizes scientific risks through AI-driven antibody design and global alliances, although dependence on clinical trial outcomes creates uncertainty. The cash per share level offsets these concerns, where the 1.93 mark serves as a key liquidity metric. This confirms the company's pricing power driven by SAFEbody, which enables the creation of safe cancer therapies.
Comprehensive metric breakdowns and analytics for Adagene Corp (ADAG)

Cash per share measures the volume of net liquidity available per security to ensure operational stability. Investors compare this calculation with the market price to determine the capital's margin of safety. According to GURU.Markets data, the cash per share value is 1.93. This metric is critical for Adagene (ADAG), which funds AI developments in oncology. The availability of liquidity, combined with international partnerships, minimizes financial risks during antibody creation.